HMGB1 and familial pancreatic carcinoma: In pancreatic cancer, it was reported that HMGB1 or its receptor RAGE by RNAi or antisense nucleotide could inhibit cell invasion and augment chemotherapy sensitivity partly by down-regulation of autophagy [47].